XTL Biopharmaceuticals Ltd/ADR

CIK 1696804 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for XTL Biopharmaceuticals Ltd/ADR.

Recent SEC filings

FiledFormAccession number
Mar 17, 2026424B30001019155-26-000126
Dec 23, 2025424B30001019155-25-000520
Dec 15, 2025424B30001019155-25-000493
Feb 8, 2017424B30001019155-17-000028